Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 18, 2023 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical Announces Positive Results of EUPHAS-2 Clinical Trial Evaluating PMX in Critically Ill Endotoxemic Septic Shock Patients

Reports 28-day mortality of just 36% for patients undergoing PMX hemoadsorption versus75% predicted by widely accepted SAPS II mortality estimation tool Results featured in premier peer-reviewed...
April 06, 2023 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical Announces Investor Update Conference Call

TORONTO, April 06, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic...
March 24, 2023 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical Announces Fourth Quarter and Fiscal 2022 Results and Provides Corporate Update

Reports significant enhancements to accelerate Tigris patient enrollment including appointment of new Contract Research Organization Management to host Investor Day on April 6, 2023 TORONTO, March ...
March 09, 2023 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical Announces the Opening of Two Additional Tigris Clinical Trial Sites

TORONTO, March 09, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic...
January 12, 2023 07:30 ET | Source: Spectral Medical Inc.

Spectral Medical Provides Update on Tigris Clinical Trial and Other Business Developments

50 Patients Randomized to Date out of the 150 Total Target to be Enrolled Reports Significant Uptick in Screening and Enrollment Activities TORONTO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Spectral...
December 13, 2022 07:30 ET | Source: Spectral Medical Inc.

Spectral Medical Announces Strategic Joint Venture With Infomed to Accelerate Commercialization of Dimi and Sami Dialysis Devices

TORONTO, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock,...
November 10, 2022 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical Announces Third Quarter Results and Provides Corporate Update

TORONTO, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock,...
November 02, 2022 09:29 ET | Source: Spectral Medical Inc.

Spectral Medical Inc. Closes $10.8 Million Public Offering and Concurrent Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (TSX: EDT) (“Spectral” or the...
October 06, 2022 17:00 ET | Source: Spectral Medical Inc.

Spectral Medical Inc. Announces Pricing of Previously Announced Offering

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (TSX: EDT) (“Spectral” or the...
October 05, 2022 16:26 ET | Source: Spectral Medical Inc.

Spectral Medical Inc. Announces Proposed Public Offering of Units and Private Placement of Notes

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (TSX: EDT) (“Spectral” or the...